Remote - Remote, IN
Management
Management
Apply for this positionBack to Jobs
Libris is poised to transform life sciences—and for millions of people, even life itself.
LIBRIS Innovations (a subsidiary of IBRI) is seeking a Venture Partner to play a defining role in building and launching new biotech companies from IBRI's research portfolio and affiliated external sources. This role is deeply rooted in business development and venture creation , requiring an individual who can both identify high-potential scientific assets and translate them into compelling commercial opportunities that attract capital and strategic partnerships.
This is a senior role for a rare individual who combines deep scientific expertise with hands-on company-building experience and the investor instincts of a seasoned life sciences VC. The ideal candidate operates at the intersection of science, capital formation, and strategic deal-making; someone who has built companies from the ground up, understands how to position opportunities for investment, and can confidently engage investors, partners, and stakeholders to drive growth and funding.
In profile, this role is analogous to a VP or Principal at a leading life sciences venture firm, but with a decisive orientation toward execution and venture development. This is fundamentally an operator role with a strong external, market-facing component , responsible for shaping company narratives, building investor syndicates, and forging strategic partnerships that accelerate company success.
The Venture Partner will work in close partnership with the Libris CEO across the full lifecycle of company creation; from opportunity sourcing and diligence through launch and fundraising; while also playing a key role in expanding Libris’ external network, strengthening its brand in the venture ecosystem, and driving long-term platform growth.
Compensation includes a base salary and performance bonus through Libris. In addition, for newcos in which the Venture Partner plays an extensive role in creation and launch, equity participation at the newco level may be considered on a case-by-case basis.
Libris is the venture creation arm of IBRI (Indiana Biosciences Research Institute), purpose-built to translate world-class science into transformative life sciences companies. We identify, validate, and build new companies from IBRI's research portfolio and through strategic external partnerships — spanning earlystage ideation, company formation, fundraising, and beyond. Libris operates with the conviction that the best companies are built at the intersection of exceptional science, disciplined execution, and patient capital.
Equal Employment Opportunity: LIBRIS provides equal employment opportunities to all employees and applicants and does not discriminate based on age, race, color, religion, gender, sexual orientation, gender identity, gender expression, national origin, protected veteran status, disability, or any other legally protected status.
Apply for this position
Powered by [HiringThing](https://www.hiringthing.com) © 2026 | [Privacy Policy](https://indiana-biosciences-research-institute-inc.hiringthing.com/agreements/applicant_privacy_policy)
[Admin Login](https://indiana-biosciences-research-institute-inc.hiringthing.com/users/login/) | [Subscribe via RSS](https://indiana-biosciences-research-institute-inc.hiringthing.com/api/rss.xml)
The Indiana Biosciences Research Institute (IBRI) is a first-in-class translational medicine institute dedicated to advancing life sciences in the race to eliminate disease and improve human health and life. By ambitiously translating cutting-edge life science discoveries into potential new therapeutics—and backed by the mission and resources of industry leaders, investors, and philanthropic partners—IBRI is successfully evolving a new, independent model to conquer disease, uniting previously fragmented forces in the quest for cures. Carefully curating and supporting early-stage companies with investment, talent, and space, IBRI strategically accelerates drug discovery. Our work benefits from the relatively low cost of living and doing business here, allowing more resources to be directed toward science. Fueled by the same entrepreneurial creativity as the groundbreaking scientific work we support, IBRI’s labs advance research across the frontiers of diabetes, metabolic disease, Alzheimer’s disease, and rare pediatric diseases. Our ambitious public–private vision cultivates talent while efficiently bridging the gap between research-driven inquiry and profit-driven drug development. At IBRI, cures are launched on a clear pathway to clinical trials, enabled by the combined resources and experience of our academic and industry partners, without the typical pressure to deliver rapid results for commercialization. IBRI labs pursue breakthroughs that might never happen elsewhere. Breakthroughs are happening here. Our novel financing model ensures that when discoveries are ready for clinical trials, the intellectual property is sold back to industry or spun off, creating a direct stream of revenue. By every measure, the IBRI model demonstrates a novel approach that delivers rewards. Scientific bench work is nurtured, drug discovery is advanced, workforce development is continuous, investors see returns, and donors see impact.
View company profile →